Product Information
LEVALBUTEROL 1.25 MG/3 ML SOL is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2731 per ML under NDC 00378969252. Its NADAC has been published 404 times since Jan 9, 2019.
FDA first approved this application on Mar 22, 2016. Its Orange Book therapeutic-equivalence code is AN.
Strength
1.25 mg/3mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378969252
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
LEVALBUTEROL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203653FDA Approved
3/22/2016
TE Code
AN
On Market Since
9/10/2018
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has been published 404 times since Jan 9, 2019, and over the history we have for it it has risen 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2731 per ML |
|---|---|
| All-time high | $0.3525 (Nov 11, 2020) |
| All-time low | $0.2201 (Jul 17, 2024) |
| 52-week high | $0.2769 |
| 52-week low | $0.2578 |
| Median price | $0.2760 |
| Average price | $0.2807 |
| Largest weekly change | +40.8% (Nov 22, 2023) |
| Weeks tracked | 404 |
| Tracking since | Jan 9, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levalbuterol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 1.25 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 1.25 MG/3 ML SOL, manufactured by Mylan Pharmaceuticals Inc., is $0.2731 per ML (NDC 00378969252), effective Sep 30, 2026.
How has the price of LEVALBUTEROL 1.25 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has risen 7.3%. It has been tracked across 404 weekly CMS publications since Jan 9, 2019.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 1.25 MG/3 ML SOL?
Since Jan 9, 2019, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has ranged from a low of $0.2201 (Jul 17, 2024) to a high of $0.3525 (Nov 11, 2020), with a median of $0.2760 per ML.
Are there cheaper alternatives to LEVALBUTEROL 1.25 MG/3 ML SOL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVALBUTEROL 1.25 MG/3 ML SOL in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVALBUTEROL 1.25 MG/3 ML SOL?
LEVALBUTEROL 1.25 MG/3 ML SOL (NDC 00378969252) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.